These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Requirement of a reactive alpha, beta-unsaturated carbonyl for inhibition of tumor growth and induction of differentiation by "A" series prostaglandins. Honn KV; Marnett LJ Biochem Biophys Res Commun; 1985 May; 129(1):34-40. PubMed ID: 4039934 [TBL] [Abstract][Full Text] [Related]
4. [Action of prostaglandin A2 on the proliferation and morphologic differentiation of murine neuroblastoma cell line]. Adolphe M; Giroud JP; Fontagne J; Lechat P; Timsit J C R Seances Soc Biol Fil; 1974; 168(6-7):694-8. PubMed ID: 4282032 [No Abstract] [Full Text] [Related]
5. Modulation of the growth of a human erythroleukemic cell line (K562) by prostaglandins: antiproliferative action of prostaglandin A. Santoro MG; Crisari A; Benedetto A; Amici C Cancer Res; 1986 Dec; 46(12 Pt 1):6073-7. PubMed ID: 2430689 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of human malignant melanoma colony-forming cells in vitro by prostaglandin A1. Bregman MD; Meyskens FL Cancer Res; 1983 Apr; 43(4):1642-5. PubMed ID: 6572555 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of human melanoma growth by prostaglandin A, D, and J analogues. Bregman MD; Funk C; Fukushima M Cancer Res; 1986 Jun; 46(6):2740-4. PubMed ID: 3698005 [TBL] [Abstract][Full Text] [Related]
8. The effects of prostaglandin A1 and prostaglandin B1 on the differentiation of cartilage in the chick embryo. Kirkpatrick CJ Cell Tissue Res; 1980; 210(1):111-20. PubMed ID: 7407857 [TBL] [Abstract][Full Text] [Related]
9. Modulation of human hematopoiesis by prostaglandins and lithium. Chan HS; Saunders EF; Freedman MH J Lab Clin Med; 1980 Jan; 95(1):125-32. PubMed ID: 6243155 [No Abstract] [Full Text] [Related]
10. Control of the growth of a human erythroleukemic cell line by prostaglandins. Santoro MG; Amici C Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():969-71. PubMed ID: 2960213 [No Abstract] [Full Text] [Related]
11. Effects of tocopherol (vitamin E) acid succinate on morphological alterations and growth inhibition in melanoma cells in culture. Prasad KN; Edwards-Prasad J Cancer Res; 1982 Feb; 42(2):550-5. PubMed ID: 6275980 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of epidermal growth factor binding by prostaglandin A's. Lee LS Biochem Biophys Res Commun; 1981 Oct; 102(4):1144-50. PubMed ID: 6274331 [No Abstract] [Full Text] [Related]
13. Effects of cyclopentenone prostaglandins on myeloid cells during early infection with HTLV-I. I. Cell differentiation determines sensitivity to prostaglandins and virus infection. Lacal PM; Puglianiello A; Bonmassar E; D'Onofrio C J Pharmacol Exp Ther; 1994 Nov; 271(2):1086-95. PubMed ID: 7965770 [TBL] [Abstract][Full Text] [Related]
14. Cell cycle effects of prostaglandins A1, A2, and D2 in human and murine melanoma cells in culture. Bhuyan BK; Adams EG; Badiner GJ; Li LH; Barden K Cancer Res; 1986 Apr; 46(4 Pt 1):1688-93. PubMed ID: 3456266 [TBL] [Abstract][Full Text] [Related]
15. Dexamethasone, prostaglandin A, and retinoic acid modulation of murine and human melanoma cells grown in soft agar. Bregman MD; Peters E; Sander D; Meyskens FL J Natl Cancer Inst; 1983 Nov; 71(5):927-32. PubMed ID: 6580494 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the effects of different retinoids on the growth and differentiation of a human melanoma cell line and selected subclones. Meyskens FL; Fuller BB Cancer Res; 1980 Jul; 40(7):2194-6. PubMed ID: 6770995 [TBL] [Abstract][Full Text] [Related]
17. Chronic effects of PGBx, a polymeric prostaglandin, on blood leukocyte counts. Polis E; Cope FW Physiol Chem Phys; 1982; 14(5):431-7. PubMed ID: 7186639 [TBL] [Abstract][Full Text] [Related]
18. Effects of growth factors on the antiproliferative activity of tumor necrosis factors. Sugarman BJ; Lewis GD; Eessalu TE; Aggarwal BB; Shepard HM Cancer Res; 1987 Feb; 47(3):780-6. PubMed ID: 3802082 [TBL] [Abstract][Full Text] [Related]
19. Unmasking by soluble IL-6 receptor of IL-6 effect on metastatic melanoma: growth inhibition and differentiation of B16-F10.9 tumor cells. Oh JW; Katz A; Harroch S; Eisenbach L; Revel M; Chebath J Oncogene; 1997 Jul; 15(5):569-77. PubMed ID: 9247310 [TBL] [Abstract][Full Text] [Related]
20. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor. Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]